ChemRxiv
These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
1/1
2 files

Direct Carbon Isotope Exchange of Pharmaceuticals via Reversible Decyanation

preprint
submitted on 17.02.2021, 23:26 and posted on 18.02.2021, 13:23 by Minghao Feng, Joao De Oliveira, Antoine Sallustrau, Gianluca Destro, Pierre Thuéry, Sebastien Roy, Thibault Cantat, Charles S. Elmore, Jörg Blankenstein, Frédéric Taran, Davide Audisio
The incorporation of carbon-14 allows tracking of organic molecules and provides vital knowledge on their fate. This information is critical in pharmaceutical development, crop science and human food safety evaluation. Herein, a transition-metal-catalyzed procedure enabling carbon isotope exchange on aromatic nitriles is described. Utilizing the radiolabeled precursor Zn([14C]CN)2, this protocol allows the insertion of the desired carbon tag without need of structural modifications, in a single step. Reducing synthetic costs and limiting the generation of radioactive waste, this procedure will facilitate the labeling of nitrile containing drugs and accelerate 14C-based ADME studies supporting drug development.

History

Email Address of Submitting Author

davide.audisio@cea.fr

Institution

CEA-Saclay (Université Paris Saclay)

Country

France

ORCID For Submitting Author

0000-0002-6234-3610

Declaration of Conflict of Interest

no conflict of interest

Exports

ChemRxiv

Exports